Literature DB >> 17393160

Acetyl-[Asn30,Tyr32]-calcitonin fragment 8-32 forms channels in phospholipid planar lipid membranes.

Daniela Meleleo1, Enrico Gallucci, Vittorio Picciarelli, Silvia Micelli.   

Abstract

The N-terminally truncated derivative of salmon calcitonin (sCt) (acetyl-[Asn(30),Tyr(32)]-calcitonin fragment 8-32) (AC 187) lacks hormonal activity and is a potent and selective antagonist of the hormone and amylin receptor. It was investigated for its capability to interact and form channels in palmitoleoylphosphatidylcholine:dioleoylphosphatidylglycerol planar lipid membranes. Interestingly, AC 187 exhibits channel activity, whose parameters, i.e., central conductance (Lambda (c)), occurrence (number of channels/min), voltage-dependence and lifetime, are similar to those found for sCt although, in the same experimental conditions, it takes longer to incorporate into the membrane than sCt. This channel activity can be modulated by changing either the holding potential or the pH of the medium, or by adding picomolar concentrations of SDS. One evident difference between the two peptides is that sCt is unselective (1.03) while AC 187 displays a cationic selectivity (P (K) (+)/P (Cl) (-) = 2.7) at pH 7, increasing to 3.87 when the pH drops to 3.8. The present findings indicate that the 1-7 disulfide bridge is sufficient but not necessary for membrane interaction, in accordance with the observation reported on the interaction with membrane receptors. Furthermore, the remarkable pH dependence of the cationic channel could be taken into consideration for full biotechnological study.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17393160     DOI: 10.1007/s00249-007-0150-6

Source DB:  PubMed          Journal:  Eur Biophys J        ISSN: 0175-7571            Impact factor:   2.095


  38 in total

1.  Conformational flexibility in calcitonin: the dynamic properties of human and salmon calcitonin in solution.

Authors:  P Amodeo; A Motta; G Strazzullo; M A Castiglione Morelli
Journal:  J Biomol NMR       Date:  1999-02       Impact factor: 2.835

2.  Calcitonin forms oligomeric pore-like structures in lipid membranes.

Authors:  Marco Diociaiuti; Laura Zanetti Polzi; Luisa Valvo; Fiorella Malchiodi-Albedi; Cecilia Bombelli; Maria Cristina Gaudiano
Journal:  Biophys J       Date:  2006-09-15       Impact factor: 4.033

3.  Amylin stimulates proximal tubular sodium transport and cell proliferation in the rat kidney.

Authors:  P J Harris; M E Cooper; S Hiranyachattada; J L Berka; D J Kelly; M Nobes; P J Wookey
Journal:  Am J Physiol       Date:  1997-01

4.  Membrane surface-associated helices promote lipid interactions and cellular uptake of human calcitonin-derived cell penetrating peptides.

Authors:  Michael E Herbig; Kathrin Weller; Ulrike Krauss; Annette G Beck-Sickinger; Hans P Merkle; Oliver Zerbe
Journal:  Biophys J       Date:  2005-09-23       Impact factor: 4.033

5.  Structure/function relationships of calcitonin analogues as agonists, antagonists, or inverse agonists in a constitutively activated receptor cell system.

Authors:  G Pozvek; J M Hilton; M Quiza; S Houssami; P M Sexton
Journal:  Mol Pharmacol       Date:  1997-04       Impact factor: 4.436

6.  Membrane lipid phase as catalyst for peptide-receptor interactions.

Authors:  D F Sargent; R Schwyzer
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

7.  Determinants for calcitonin analog interaction with the calcitonin receptor N-terminus and transmembrane-loop regions.

Authors:  S D Stroop; H Nakamuta; R E Kuestner; E E Moore; R M Epand
Journal:  Endocrinology       Date:  1996-11       Impact factor: 4.736

8.  Selective amylin antagonist suppresses rise in plasma lactate after intravenous glucose in the rat. Evidence for a metabolic role of endogenous amylin.

Authors:  A A Young; B Gedulin; L S Gaeta; K S Prickett; K Beaumont; E Larson; T J Rink
Journal:  FEBS Lett       Date:  1994-05-02       Impact factor: 4.124

9.  The effect of thyrocalcitonin on blood-bone calcium equilibrium in the perfused tibia of the cat.

Authors: 
Journal:  J Physiol       Date:  1967-07       Impact factor: 5.182

10.  Enhanced potency of human calcitonin when fibrillation is avoided.

Authors:  A Cudd; T Arvinte; R E Das; C Chinni; I MacIntyre
Journal:  J Pharm Sci       Date:  1995-06       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.